Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957

Watchlist Manager
Yunnan Botanee Bio-Technology Group Co Ltd Logo
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Watchlist
Price: 45.43 CNY -0.81% Market Closed
Market Cap: 19.2B CNY
Have any thoughts about
Yunnan Botanee Bio-Technology Group Co Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one Yunnan Botanee Bio-Technology Group Co Ltd stock under the Base Case scenario is 70.74 CNY. Compared to the current market price of 45.43 CNY, Yunnan Botanee Bio-Technology Group Co Ltd is Undervalued by 36%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
70.74 CNY
Undervaluation 36%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.2
P/S
P/S
Price to Sales
3.2
vs History
86
vs Industry
13
Median 3Y
8.4
Median 5Y
11.7
Industry
1
Forward
3
More Details
24.1
P/E
P/E
Price to Earnings
24.1
vs History
84
vs Industry
20
Median 3Y
40.3
Median 5Y
54.7
Industry
16.8
Forward
22
More Details
40.9
P/OCF
P/OCF
Price to OCF
40.9
vs History
67
vs Industry
10
Median 3Y
56.2
Median 5Y
63
Industry
11.9
More Details
27.9
P/FCFE
P/FCFE
Price to FCFE
27.9
vs History
86
vs Industry
9
Median 3Y
80.5
Median 5Y
92
Industry
17.6
More Details
3.2
P/B
P/B
Price to Book Value
3.2
vs History
86
vs Industry
16
Median 3Y
7.9
Median 5Y
10.5
Industry
1.6
More Details
2.8
EV/S
EV/S
Enterprise Value to Sales
2.8
vs History
84
vs Industry
17
Median 3Y
7.7
Median 5Y
10.9
Industry
1.2
Forward
2.6
More Details
3.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.9
vs History
84
vs Industry
40
Median 3Y
10.5
Median 5Y
14.6
Industry
3.8
More Details
19.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.6
vs History
82
vs Industry
15
Median 3Y
35.8
Median 5Y
48.7
Industry
10.3
Forward
15.3
More Details
19.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
19.6
vs History
82
vs Industry
19
Median 3Y
35.8
Median 5Y
48.7
Industry
12.9
Forward
20.4
More Details
35.6
EV/OCF
EV/OCF
Enterprise Value to OCF
35.6
vs History
67
vs Industry
13
Median 3Y
50.9
Median 5Y
60.2
Industry
12.1
More Details
138.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
138.6
vs History
17
vs Industry
8
Median 3Y
117.6
Median 5Y
124.5
Industry
15.3
More Details
3.9
EV/IC
EV/IC
Enterprise Value to IC
3.9
vs History
86
vs Industry
11
Median 3Y
14.2
Median 5Y
17.7
Industry
1.2
More Details

Multiples Across Competitors

Competitors Multiples
Yunnan Botanee Bio-Technology Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
19.1B CNY 3.2 24.1 19.6 19.6
FR
L'Oreal SA
PAR:OR
181.7B EUR 4.3 28 18.7 22.2
UK
Unilever PLC
LSE:ULVR
114.1B GBP 2.3 20.7 177.4 204
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR 8.8 53.1 36.5 39.8
UK
HALEON PLC
LSE:HLN
34.9B GBP 3.1 28.9 17.2 19.7
DE
Beiersdorf AG
XETRA:BEI
27.8B EUR 2.9 37.6 16 22.9
US
Estee Lauder Companies Inc
NYSE:EL
27B USD 1.7 132.8 13.1 19.9
JP
Kao Corp
TSE:4452
3T JPY 1.9 36 14.3 25.8
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.1T INR 7.9 -297.8 35.4 37.8
IN
Dabur India Ltd
NSE:DABUR
903.7B INR 7.3 50.5 38.3 46.7
US
Bellring Brands Inc
NYSE:BRBR
9.9B USD 4.9 40.1 25.1 27.4
P/E Multiple
Earnings Growth P/E to Growth
CN
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Average P/E: 45.2
24.1
63%
0.4
FR
L'Oreal SA
PAR:OR
28
30%
0.9
UK
Unilever PLC
LSE:ULVR
20.7
25%
0.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
53.1
32%
1.6
UK
HALEON PLC
LSE:HLN
28.9
-7%
N/A
DE
Beiersdorf AG
XETRA:BEI
37.6
61%
0.6
US
Estee Lauder Companies Inc
NYSE:EL
132.8
245%
0.5
JP
Kao Corp
TSE:4452
36
205%
0.2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
Negative Multiple: -297.8 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
50.5
39%
1.3
US
Bellring Brands Inc
NYSE:BRBR
40.1
56%
0.7

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.